Table 1 Patient characteristics

Male/female

35/92

Median age (range)

50 (19–89) years

Median body weight (range)

53 (35–87) kg

Chemotherapy risk for CINV^a

 HEC^b regimens, n (%)

96 (76%)

 MEC^c regimens, n (%)

25 (20%)

 LEC^d regimens, n (%)

6 (5%)

Baseline CINV grades

 Grade 1, n (%)

23 (18%)

 Grade 2, n (%)

88 (69%)

 Grade 3, n (%)

16 (13%)

 Grade 4, n (%)

None

Olanzapine doses

 10 mg/day, n (%)

4 (3%)

 5 mg/day, n (%)

94 (74%)

 2.5 mg/day, n (%)

29 (23%)